Búsqueda | Portal de Búsqueda de la BVS Enfermería

1.

Bone Fragility Fractures in CKD Patients.

Pimentel, Ana; Ureña-Torres, Pablo; Bover, Jordi; Luis Fernandez-Martín, Jose; Cohen-Solal, Martine.

Calcif Tissue Int ; 108(4): 539-550, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33219822

2.

The Non-invasive Diagnosis of Bone Disorders in CKD.

Bover, Jordi; Ureña-Torres, Pablo; Cozzolino, Mario; Rodríguez-García, Minerva; Gómez-Alonso, Carlos.

Calcif Tissue Int ; 108(4): 512-527, 2021 04.

Artículo en Inglés | MEDLINE | ID: mdl-33398414

3.

Electrochemical skin conductance by Sudoscan®: a new tool to predict intradialytic hypotension.

Reach, Pauline; Touzot, Maxime; Lombardi, Yannis; Maheas, Catherine; Sacco, Emmanuelle; Fels, Audrey; Beaussier, Hélène; Ureña-Torres, Pablo; Chatellier, Gilles; Ridel, Christophe; Zuber, Mathieu.

Nephrol Dial Transplant ; 36(8): 1511-1518, 2021 07 23.

Artículo en Inglés | MEDLINE | ID: mdl-34021358

4.

The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.

Tabibzadeh, Nahid; Karaboyas, Angelo; Robinson, Bruce M; Csomor, Philipp A; Spiegel, David M; Evenepoel, Pieter; Jacobson, Stefan H; Ureña-Torres, Pablo-Antonio; Fukagawa, Masafumi; Al Salmi, Issa; Liang, Xinling; Pisoni, Ronald L; Young, Eric W.

Nephrol Dial Transplant ; 36(1): 160-169, 2021 01 01.

Artículo en Inglés | MEDLINE | ID: mdl-33068419

5.

Cortical Bone Microarchitecture in Dialysis Patients.

Benillouche, Eva; Ostertag, Agnes; Marty, Caroline; Ureña Torres, Pablo; Cohen-Solal, Martine.

Am J Nephrol ; 51(10): 833-838, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-32911468

6.

Valvular heart disease and calcification in CKD: more common than appreciated.

Ureña-Torres, Pablo; D'Marco, Luis; Raggi, Paolo; García-Moll, Xavier; Brandenburg, Vincent; Mazzaferro, Sandro; Lieber, Ari; Guirado, Lluis; Bover, Jordi.

Nephrol Dial Transplant ; 35(12): 2046-2053, 2020 12 04.

Artículo en Inglés | MEDLINE | ID: mdl-31326992

7.

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.

Bushinsky, David A; Chertow, Glenn M; Cheng, Sunfa; Deng, Hongjie; Kopyt, Nelson; Martin, Kevin J; Rastogi, Anjay; Ureña-Torres, Pablo; Vervloet, Marc; Block, Geoffrey A.

Nephrol Dial Transplant ; 35(10): 1769-1778, 2020 10 01.

Artículo en Inglés | MEDLINE | ID: mdl-30859218

8.

Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?

Mazzaferro, Sandro; Cianciolo, Giuseppe; De Pascalis, Antonio; Guglielmo, Chiara; Urena Torres, Pablo A; Bover, Jordi; Tartaglione, Lida; Pasquali, Marzia; La Manna, Gaetano.

Nephrol Dial Transplant ; 33(12): 2092-2100, 2018 12 01.

Artículo en Inglés | MEDLINE | ID: mdl-29733407

9.

Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.

Pimentel, Ana; Ureña-Torres, Pablo; Zillikens, M Carola; Bover, Jordi; Cohen-Solal, Martine.

Kidney Int ; 92(6): 1343-1355, 2017 12.

Artículo en Inglés | MEDLINE | ID: mdl-28964571

10.

Parathyroid hormone metabolism and signaling in health and chronic kidney disease.

Evenepoel, Pieter; Bover, Jordi; Ureña Torres, Pablo.

Kidney Int ; 90(6): 1184-1190, 2016 12.

Artículo en Inglés | MEDLINE | ID: mdl-27653840

11.

Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry.

Mercadal, Lucile; Franck, Jeanna-Eve; Metzger, Marie; Urena Torres, Pablo; de Cornelissen, François; Edet, Stéphane; Béchade, Clémence; Vigneau, Cécile; Drüeke, Tilman; Jacquelinet, Christian; Stengel, Bénédicte.

Am J Kidney Dis ; 68(2): 247-255, 2016 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-26724836

12.

Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

Brandenburg, Vincent M; Evenepoel, Pieter; Floege, Jürgen; Goldsmith, David; Kramann, Rafael; Massy, Ziad; Mazzaferro, Sandro; Schurgers, Leon J; Sinha, Smeeta; Torregrosa, Vicens; Ureña-Torres, Pablo; Vervloet, Marc; Cozzolino, Mario.

Nephrol Dial Transplant ; 31(8): 1211-9, 2016 08.

Artículo en Inglés | MEDLINE | ID: mdl-27005994

13.

Pro: cardiovascular calcifications are clinically relevant.

Bover, Jordi; Evenepoel, Pieter; Ureña-Torres, Pablo; Vervloet, Marc G; Brandenburg, Vincent; Mazzaferro, Sandro; Covic, Adrian; Goldsmith, David; Massy, Ziad A; Cozzolino, Mario.

Nephrol Dial Transplant ; 30(3): 345-51, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25712934

14.

Sodium thiosulphate treatment of uraemic tumoral calcinosis.

Malbos, Stéphanie; Urena-Torres, Pablo; Cohen-Solal, Martine; Trout, Hervé; Lioté, Frédéric; Bardin, Thomas; Ea, Hang-Korng.

Rheumatology (Oxford) ; 53(3): 547-51, 2014 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-24292346

15.

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Cozzolino, Mario; Ureña-Torres, Pablo; Vervloet, Marc G; Brandenburg, Vincent; Bover, Jordi; Goldsmith, David; Larsson, Tobias E; Massy, Ziad A; Mazzaferro, Sandro.

Nephrol Dial Transplant ; 29(10): 1815-20, 2014 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-24516228

16.

Erratum.

Bushinsky, David A; Chertow, Glenn M; Cheng, Sunfa; Deng, Hongjie; Kopyt, Nelson; Martin, Kevin J; Rastogi, Anjay; Ureña-Torres, Pablo; Vervloet, Marc; Block, Geoffrey A.

Nephrol Dial Transplant ; : 1642, 2019 05 15.

Artículo en Inglés | MEDLINE | ID: mdl-31093680

17.

Not all hyperphosphataemias should be treated.

Ureña Torres, Pablo Antonio; Cohen-Solal, Martine.

Nephrol Dial Transplant ; 34(7): 1077-1079, 2019 07 01.

Artículo en Inglés | MEDLINE | ID: mdl-30403809

18.

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial.

Ureña-Torres, Pablo; Prié, Dominique; Keddad, Karim; Preston, Peter; Wilde, Paul; Wan, Hong; Copley, J Brian.

BMC Nephrol ; 15: 71, 2014 May 05.

Artículo en Inglés | MEDLINE | ID: mdl-24885942

19.

The Authors Reply.

Cohen-Solal, Martine; Ureña-Torres, Pablo Antonio.

Kidney Int ; 93(5): 1247, 2018 05.

Artículo en Inglés | MEDLINE | ID: mdl-29680023

20.

The Authors Reply.

Ureña-Torres, Pablo Antonio; Cohen-Solal, Martine.

Kidney Int ; 93(5): 1248-1249, 2018 05.

Artículo en Inglés | MEDLINE | ID: mdl-29680024

Portal de Búsqueda de la BVS Enfermería

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Bone Fragility Fractures in CKD Patients.

The Non-invasive Diagnosis of Bone Disorders in CKD.

Electrochemical skin conductance by Sudoscan®: a new tool to predict intradialytic hypotension.

The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.

Cortical Bone Microarchitecture in Dialysis Patients.

Valvular heart disease and calcification in CKD: more common than appreciated.

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.

Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?

Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.

Parathyroid hormone metabolism and signaling in health and chronic kidney disease.

Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry.

Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?

Pro: cardiovascular calcifications are clinically relevant.

Sodium thiosulphate treatment of uraemic tumoral calcinosis.

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Erratum.

Not all hyperphosphataemias should be treated.

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial.

The Authors Reply.

The Authors Reply.